Implantable cardioverter-defibrillator lead performance

Circulation

Volumn 117, Issue 21, 2008, Pages 2721-2723

  Maisel, William H ^a   Kramer, Daniel B ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Death, sudden; Defibrillation; Editorials; Registries; Tachyarrhythmias

Indexed keywords

AUTOMATION; BIOLOGICAL MONITORING; CONDUCTOR; DEFIBRILLATOR; EDITORIAL; ELECTRODE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; PERFORMANCE; PRIORITY JOURNAL; RELIABILITY; REOPERATION; SUDDEN DEATH; TREATMENT FAILURE;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; HUMANS; REGISTRIES; RISK FACTORS; TACHYCARDIA;

EID: 44449150680     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.776807     Document Type: Editorial

References (13)

1. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-324.
2. Maisel WH. Transvenous implantable cardioverter defibrillator leads: the weakest link. Circulation. 2007;115:2461-2463.
3. Eckstein J, Koller MT, Zabel M, Kalusche D, Schaer BA, Osswald S, Sticherling C. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation. 2008;117:21:2727-2733.
4. Aass H, Ilvento J. Short and medium time experience with a tined, multilumen steroid eluting defibrillation lead. J Interv Card Electrophysiol. 2002;6:81-86.
5. Kron J, Herre J, Renfroe EG, Rizo-Patron C, Raitt M, Halperin B, Gold M, Goldner B, Wathen M, Wilkoff B, Olarte A, Yao Q. Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators trial. Am Heart J. 2001;141:92-98.
6. Dorwarth U, Frey B, Gugas M, Matis T, Fiek M, Schmoeckel M, Remp P, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol. 2003;14:38-43.
7. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol. 2003;41:73-80.
8. Luria D, Glikson M, Brady PA, Lexvold NY, Rasmussen MJ, Hodge DO, Chugh SS, Rea RF, Hayes DL, Hammill SC, Friedman PA. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol. 2001;87:901-904.
9. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
10. Kitamura S, Satomi K, Kurita T, Shimizu W, Suyama K, Aihara N, Niwaya K, Kobayashi J, Kamakura S. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J. 2006;70:273-277.
11. Hauser RG, Cannom D, Hayes DL, Parsonnet V, Hayes J, Ratliff N III, Tyers GF, Epstein AE, Vlay SC, Furman S, Gross J. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol. 2002;25:879-882.
12. Lindsay BD. Task Force on Lead Performance. Available at: http://www.hrsonline.org/News/taskforce_leadperformance.cfm?zbrandid= 3077&zidType=CH&zid=813428&zsubscriberId=751606938. Accessed March 30, 2008.
13. Multicenter Registry of Pacemaker, ICD Pulse Generator, and Lead Failures. Available at: http://www.pacerandicdregistry.com/mhif/. Accessed March 30, 2008.